• Family of patient who died after orthopedic surgery wins $35M verdict against hospital
  • Orthopedic surgeon wins $20M verdict against Johnson & Johnson
  • Minnesota orthopedic group hit with $111M negligence verdict
  • Orthopedic patient's death highlights potential dangers of prior authorization
  • Spine surgeon's video hits 1 million views on TikTok
  • Spine surgeon killed in Oklahoma hospital shooting
  • Spine surgeon owes $17M to paralyzed patient
  • Providence to pay $22.7M to settle unnecessary spine surgery allegations
  • Spine surgeon gets jail time for abusing patient during hospital visit
  • 'They're on really thin ice': Why 1 insurer has drawn spine surgeons' ire
  • Connecticut hospital to appeal $12.5M verdict to family of patient who died after orthopedic surgery
  • Orthopedic surgeon must face suit in patient's death
  • Spine surgeon 1 of 9 physician billionaires on Forbes' 2022 list
  • 23 spine device companies to watch in 2022
  • 4 spine technologies that promised more than they delivered
  • Orthopedic surgeon salary vs. average household income in each state
  • Orthopedic surgeon's health system exit steeped in controversy
  • Terminated orthopedic surgeon contracts with another New York hospital
  • Orthopedic surgeon convicted of battery at hospital
  • Billionaire spine surgeon buys $23.9M mansion
  • UArizona neurosurgery chair dies after motorcycle collision
  • Texas spine surgeon sued by State Farm over 'unnecessary' procedures
  • The spine tech surgeons say will explode in the next 5 years
  • Could Medtronic's spine business be the next medtech spinoff?
  • Ex-NFL player gets 5 years in prison for $2.9M healthcare fraud scheme
  • 41 'rising stars' in orthopedics
  • Orthopedic surgeon indicted in $10M telemedicine fraud scheme
  • Neurosurgeon's startup hits $1.2B valuation
  • Orthopedic surgeon fined for operating on wrong knee
  • Lawsuits build against Aetna's spine surgery coverage
  • Good news, bad news for orthopedic surgeons: 6 observations
  • Former spine surgeon owes $13M to 2 women over unnecessary procedures
  • Walmart's latest partnership pushes retailer into spine care
  • Texas spine surgeon's $11M verdict being appealed
  • 10 power players in orthopedics
  • Rothman Orthopaedics to become national brand, but no 'aspirations to go beyond US'
  • Sports medicine physician fired amid misconduct allegations involving patients
  • Orthopedic surgeon allegedly exaggerated patient visits to defraud insurers
  • Top orthopedic hospital in every state: US News
  • Orthopedic surgeon asking for misconduct charges to be dropped
  • How Medtronic is strengthening its spine business
  • $85M settlement reached in spinal cord stimulation lawsuits
  • Medtronic's next-gen predictive spine surgery model cleared
  • ZimVie's pediatric scoliosis device gets coverage by Anthem BCBS
  • Spinal fusion alternative device reaches FDA milestone
  • Stryker, Wright Medical face FTC scrutiny over $4B merger: 4 details

    Stryker, Wright Medical face FTC scrutiny over $4B merger: 4 details

    Angie Stewart -  

    Stryker's proposed merger with Wright Medical is facing additional scrutiny from the Federal Trade Commission, a Jan. 2 SEC filing shows.

    Four things to know:

    1. Wright Medical and Stryker announced in November that they signed a definitive agreement for the transaction. They filed notice with the FTC's antitrust division Dec. 16 of their intent to merge through a deal valued at $4 billion in total equity.

    2. On Dec. 31, the companies each received a second request from the FTC, which extends the review period and typically seeks additional documents about company services, market conditions and likely competitive effects of the merger.

    3. The additional hurdle comes as no surprise to analysts, who quickly predicted a challenge from the FTC due to Wright Medical's focus on lower extremities and small bones.

    4. Stryker executives also indicated they were aware of potential obstacles. They predicted during a Nov. 4 conference call that the transaction won't close until the third quarter of 2020.

    "We have a lot of work to get through to close and integrate, and as I referenced before, we think the portfolios are highly complementary, but it is just premature to start talking about what products we may or may not discontinue going forward," said Katherine Owen, Stryker's vice president of strategy and investor relations.

    Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

    Featured Learning Opportunities

    Featured Webinars

    Featured Podcast

    Featured Whitepapers